Loading...
01/10 18:52
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlighted strong financial performance with a 42% revenue increase, improved net income, and a higher operating margin. Despite some risks like increased MLR and regulatory challenges, the overall outlook is optimistic, with opportunities from competitor exits and stable guidance. The lack of a share repurchase program is a minor drawback, but the positive financial results and growth prospects suggest a positive stock price movement over the next two weeks.
Total Revenue $3 billion, a 42% increase year-over-year.
Net Income Approximately $275 million, a significant improvement of $98 million over the prior year period.
Earnings from Operations $297 million, an increase of $112 million year-over-year.
Operating Margin 9.8%, a 110 basis point increase year-over-year.
Medical Loss Ratio (MLR) 75.4%, an increase of 120 basis points year-over-year, primarily due to risk adjustment true up for 2024.
SG&A Expense Ratio 15.8%, a 260 basis point improvement year-over-year, driven by fixed cost leverage, lower exchange fee rates, and variable cost efficiencies.
Adjusted EBITDA $329 million, an improvement of approximately $110 million year-over-year.
Cash and Investments Approximately $4.9 billion, including $150 million of cash investments at the parent.
Capital and Surplus Approximately $1.5 billion, including $907 million of excess capital, driven by strong operating performance.
Oscar Community Resources: Launched Oscar Community Resources with Find Help, a social care network connecting members with local food, housing, transportation, and other services.
Virtual Urgent Care: Introduced a free live chat feature for Oscar, Virtual Urgent Care, which decreased member response times by 90% and improved provider efficiency by 28%.
AI Tool for Care Guides: New AI tool for care guides is addressing member needs more quickly.
Membership Growth: Closed the quarter with approximately 2 million effectuated members, a 41% increase year-over-year.
Market Positioning: Oscar is one of the fastest growing players in the individual insurance market, advocating for solutions that strengthen the individual market.
SG&A Ratio: Reported the lowest SG&A ratio in the company's history at 15.8%, a 260 basis point improvement year-over-year.
Operating Margin: Improved operating margin by 110 basis points year-over-year to 9.8%.
Strategic Partnerships: Deepening market presence with new partnerships to provide value-added services.
Policy Advocacy: Engaged with federal and state policymakers to advocate for constructive solutions in the individual market.
Regulatory Issues: CMS's proposed program integrity initiatives targeting fraud, waste, and abuse are seen as positive for long-term sustainability, but rules like shortened enrollment windows may constrain Americans' ability to shop for plans.
Economic Factors: Many individuals are facing meaningful premium increases, and if enhanced premium tax credits expire, they will need adequate time to shop for plans that meet their needs.
Membership Growth Challenges: The outlook contemplates the end of the monthly Special Enrollment Period (SEP) for those at or below 150% of the Federal Poverty Level (FPL), which may impact future membership growth.
Medical Loss Ratio (MLR): The first quarter MLR increased by 120 basis points year-over-year, impacted by unfavorable prior period development related to risk adjustment.
Operational Risks: Higher inpatient utilization was noted, which could affect future costs, although it was partially offset by favorable pharmacy utilization.
Total Revenue: Oscar reported total revenue of $3 billion in Q1 2025, a 42% increase year-over-year.
Net Income: Net income for Q1 2025 was approximately $275 million, a significant improvement of $98 million over the prior year.
Membership Growth: Oscar closed the quarter with approximately 2 million effectuated members, a 41% increase year-over-year.
SG&A Ratio: The SG&A ratio improved to 15.8%, a 260 basis point improvement year-over-year.
Oscar Community Resources: Launched a program connecting members with local services beyond medical care, aimed at improving clinical outcomes.
Technology Enhancements: Introduced a live chat feature for Virtual Urgent Care, reducing response times by 90% and increasing provider efficiency by 28%.
2025 Total Revenue Guidance: Oscar expects total revenue in the range of $11.2 billion to $11.3 billion for 2025.
Medical Loss Ratio Guidance: Expected MLR in the range of 80.7% to 81.7% for 2025.
SG&A Expense Ratio Guidance: Expected SG&A expense ratio in the range of 17.6% to 18.1% for 2025.
Earnings from Operations Guidance: Expected earnings from operations in the range of $225 million to $275 million for 2025.
Adjusted EBITDA Guidance: Expected adjusted EBITDA to be roughly $140 million higher than earnings from operations.
Share Repurchase Program: Oscar Health has not announced any share repurchase program during the call.
The earnings call reveals several negative trends: declining fuel and rental income, reduced site count, and lower wholesale segment profit. Despite some positive aspects like increased net income and inside sales, the overall sentiment is negative due to asset divestitures and reduced operational capacity. The Q&A section lacked engagement, indicating possible concerns about transparency. Given the company's market cap, the stock price is likely to react negatively, falling between -2% to -8% over the next two weeks.
The earnings call summary shows a mixed but overall positive sentiment. Strong financial metrics were presented, with a reaffirmed revenue guidance and improved SG&A ratio, alongside strategic partnerships. Despite concerns in the Q&A about morbidity and market shrinkage, management's confidence in pricing and profitability for 2026, along with a competitive pricing strategy, suggests a positive outlook. The market cap indicates a moderate reaction, likely resulting in a positive stock price movement within the 2% to 8% range over the next two weeks.
The earnings call summary indicates strong financial performance with a 42% revenue increase and improved net income. The guidance for 2025 remains optimistic, with expected revenue growth and controlled expenses. The Q&A section reveals proactive measures to manage risks and maintain profitability. The market cap suggests moderate sensitivity to these announcements, leading to a positive outlook for the stock price over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
